Avenga’s response to the war on Ukraine: Business Continuity and Humanitarian Aid
Avenga is a global IT and digital transformation champion, with over 20 years of experience in entrepreneurship, leadership, project delivery, customer experience, technology and staffing services. We have a passion for the digital world. Enthusiasm for technology. And a really great team. We are more than 2500 professionals with offices in Europe, the USA and Asia.
Our Pharma Research and Early Development Informatics team is the bridge between digital technology and science. We help drive medical innovation and are integral to the realisation of truly Personalised Healthcare and the development of creative treatments for our patients. Digital tools, such as smartphones or wearables, can now continually measure and collect vital health information – or “Digital Biomarkers” – from patients.
Digital Biomarkers are changing how future medicines will be developed and could lead to more personalised use of new medications that will transform the lives of patients. Advances in wearable devices, such as phones, watches, textiles or delivery devices, which track a patient’s vital signs and monitor for symptoms, all have the potential to vastly accelerate clinical development.
Digital biomarker studies are enabled by complex data collection and processing ecosystems comprising mobile applications, wearables, sensors, data lakes, data processing pipelines, analytics platforms, databases, device lifecycle management solutions etc. Currently, the use of digital biomarkers across clinical development programs is expanding significantly – generating terabytes of sensor/tracking data from dozens of studies and 10’000s of patients across global studies.
Beware of recruitment scams! We will never ask you to pay for anything.